PT94575A - Processo para a preparacao de novas citoquinas - Google Patents
Processo para a preparacao de novas citoquinasInfo
- Publication number
- PT94575A PT94575A PT94575A PT9457590A PT94575A PT 94575 A PT94575 A PT 94575A PT 94575 A PT94575 A PT 94575A PT 9457590 A PT9457590 A PT 9457590A PT 94575 A PT94575 A PT 94575A
- Authority
- PT
- Portugal
- Prior art keywords
- derivatives
- polypeptides
- preparation
- mediators
- cytokins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Control Of Transmission Device (AREA)
- Control Of Driving Devices And Active Controlling Of Vehicle (AREA)
- Radar Systems Or Details Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898915414A GB8915414D0 (en) | 1989-07-05 | 1989-07-05 | Novel cytokines |
Publications (2)
Publication Number | Publication Date |
---|---|
PT94575A true PT94575A (pt) | 1991-03-20 |
PT94575B PT94575B (pt) | 1997-02-28 |
Family
ID=10659582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94575A PT94575B (pt) | 1989-07-05 | 1990-07-03 | Processo para a preparacao de novas citoquinas |
Country Status (14)
Country | Link |
---|---|
US (2) | US5411882A (pt) |
EP (1) | EP0412050B1 (pt) |
JP (1) | JPH0356499A (pt) |
AT (1) | ATE131873T1 (pt) |
AU (1) | AU649226B2 (pt) |
CA (1) | CA2020303A1 (pt) |
DD (1) | DD298948A5 (pt) |
DE (1) | DE69024279T2 (pt) |
DK (1) | DK0412050T3 (pt) |
ES (1) | ES2081960T3 (pt) |
GB (1) | GB8915414D0 (pt) |
GR (1) | GR3018521T3 (pt) |
IE (1) | IE70519B1 (pt) |
PT (1) | PT94575B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0263072B1 (en) * | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Novel lymphokine related peptides |
ES2252732T3 (es) | 1992-05-26 | 2006-05-16 | Immunex Corporation | Nueva citoquina que une cd30. |
US6774227B1 (en) * | 1993-05-17 | 2004-08-10 | Cytokine Pharmasciences, Inc. | Therapeutic uses of factors which inhibit or neutralize MIF activity |
US6645493B1 (en) * | 1993-05-17 | 2003-11-11 | The Picower Institute For Medical Research | Composition containing anti-MIF antibody |
MY140679A (en) | 2001-05-24 | 2010-01-15 | Avanir Pharmaceuticals | Inhibitors of macrohage migration inhibitory factor and methods for identifying the same |
TW200418829A (en) * | 2003-02-14 | 2004-10-01 | Avanir Pharmaceutics | Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
WO2005021546A1 (en) | 2003-08-22 | 2005-03-10 | Avanir Pharmaceuticals | Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
US20080299128A1 (en) * | 2006-06-20 | 2008-12-04 | Myung Kim | Effect of Bst2 on inflammation |
US8329186B2 (en) * | 2004-12-20 | 2012-12-11 | Isu Abxis Co., Ltd | Treatment of inflammation using BST2 inhibitor |
CA2620626C (en) | 2004-12-20 | 2011-06-07 | Isu Abxis Co., Ltd. | Molecules inhibiting intercellular adhesion |
US7740856B2 (en) * | 2005-12-20 | 2010-06-22 | Isu Abxis Co., Ltd. | Effect of BST2 on inflammation |
CA2600175A1 (en) | 2005-03-24 | 2006-03-20 | Avanir Pharmaceuticals | Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
MXPA05011139A (es) * | 2005-10-17 | 2007-04-17 | Concretos Translucidos S De R | Formulacion para obtener una mezcla de concreto conductivo. |
GB0605689D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
US9249217B2 (en) * | 2010-12-03 | 2016-02-02 | Secretary, DHHS | Bispecific EGFRvIII x CD3 antibody engaging molecules |
WO2013050453A1 (en) | 2011-10-07 | 2013-04-11 | Baxter Healthcare S.A. | Oxmif as a diagnostic marker |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0672158B2 (ja) * | 1984-05-24 | 1994-09-14 | チバ−ガイギ− アクチエンゲゼルシヤフト | 精製されたヒトマクロファージ遊走阻止因子 |
US5008374A (en) * | 1986-03-14 | 1991-04-16 | Otsuka Pharmaceutical Co., Ltd. | IL-1α derivatives and drugs |
EP0263072B1 (en) * | 1986-10-03 | 1994-03-23 | Ciba-Geigy Ag | Novel lymphokine related peptides |
DE3855802T2 (de) * | 1987-10-02 | 1997-06-12 | The Rockefeller University, New York, N.Y. | Von Makrophagen abstammender Entzündungsvermittler(MIP-1-alpha et MIP-1-beta) |
-
1989
- 1989-07-05 GB GB898915414A patent/GB8915414D0/en active Pending
-
1990
- 1990-06-26 ES ES90810481T patent/ES2081960T3/es not_active Expired - Lifetime
- 1990-06-26 DK DK90810481.3T patent/DK0412050T3/da active
- 1990-06-26 DE DE69024279T patent/DE69024279T2/de not_active Expired - Fee Related
- 1990-06-26 AT AT90810481T patent/ATE131873T1/de not_active IP Right Cessation
- 1990-06-26 EP EP90810481A patent/EP0412050B1/en not_active Expired - Lifetime
- 1990-07-02 AU AU58095/90A patent/AU649226B2/en not_active Ceased
- 1990-07-03 CA CA002020303A patent/CA2020303A1/en not_active Abandoned
- 1990-07-03 PT PT94575A patent/PT94575B/pt not_active IP Right Cessation
- 1990-07-03 DD DD90342467A patent/DD298948A5/de not_active IP Right Cessation
- 1990-07-04 IE IE242690A patent/IE70519B1/en not_active IP Right Cessation
- 1990-07-05 JP JP2176488A patent/JPH0356499A/ja active Pending
-
1991
- 1991-12-20 US US07/811,893 patent/US5411882A/en not_active Expired - Fee Related
-
1995
- 1995-12-21 GR GR950403656T patent/GR3018521T3/el unknown
-
1996
- 1996-09-27 US US08/714,927 patent/US5821336A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2081960T3 (es) | 1996-03-16 |
IE70519B1 (en) | 1996-12-11 |
PT94575B (pt) | 1997-02-28 |
JPH0356499A (ja) | 1991-03-12 |
GB8915414D0 (en) | 1989-08-23 |
DK0412050T3 (da) | 1996-01-29 |
CA2020303A1 (en) | 1991-01-06 |
GR3018521T3 (en) | 1996-03-31 |
IE902426A1 (en) | 1991-06-19 |
AU649226B2 (en) | 1994-05-19 |
EP0412050B1 (en) | 1995-12-20 |
DE69024279D1 (de) | 1996-02-01 |
DE69024279T2 (de) | 1996-10-17 |
DD298948A5 (de) | 1992-03-19 |
ATE131873T1 (de) | 1996-01-15 |
US5411882A (en) | 1995-05-02 |
US5821336A (en) | 1998-10-13 |
AU5809590A (en) | 1991-01-10 |
EP0412050A1 (en) | 1991-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT94575A (pt) | Processo para a preparacao de novas citoquinas | |
CA2047717A1 (en) | Monoclonal antibodies for small moieties, methods therefor | |
PT868519E (pt) | Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2 | |
CY1109093T1 (el) | Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι | |
WO1991006866A3 (en) | Urinary tumor associated antigen, antigenic subunits uses and methods of detection | |
ES2057476T3 (es) | Medios para el diagnostico de neuropatias desmielinizantes, en particular de la esclerosis en placas. | |
DE69419966D1 (de) | Impstoff gegen Streptococcus suis-Infektion | |
ES2114064T3 (es) | Inmunoanalisis para la deteccion de colageno o fragmentos de colageno. | |
DE3581288D1 (de) | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. | |
ES2131066T3 (es) | Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae). | |
EP0585960A3 (en) | Diagnostic method for autoimmune diseases | |
ES542864A0 (es) | Aparato para la criofijacion de especimenes. | |
DK592086A (da) | Humant conglutinin | |
CA2062820A1 (en) | Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates | |
IT1159983B (it) | Composizione polimera vulcanizzabile procedimento per la sua preparazione e vulcanizzato ottenuto mediante rascaldamento di tale composizione | |
DE3570677D1 (en) | Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation | |
SE8403929D0 (sv) | Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase | |
DE69024814D1 (de) | Verfahren zur verbesserten herstellung von menschlichen antikörpern sowie hierzu benutzte zellen | |
FI893009A (fi) | Yttre fastsaettningsanordning. | |
BR8904681A (pt) | Uma linha de celulas de hibridoma,mutantes,anticorpos,processos para a preparacao de uma linha de celulas e para a preparacao de anticorpos e processo e agente para comprovacao imunologica de atrazina | |
SE8704485D0 (sv) | Forfarande och anordning for beredning av en suspension for metning | |
ATE78513T1 (de) | Immunoglobulin-a-rezeptor-protein (arp), sowie dessen klonierung und expression. | |
SE7904276L (sv) | Renat cancerassocierat protein | |
NO180637C (no) | Fremgangsmåte for fremstilling av monoklonale antistoffer eller fragmenter derav | |
ES2056834T3 (es) | Peptido con propiedades antigenicas aislado del grupo de proteinas 28 kd de s. mansoni y su procedimiento de separacion, anticuerpos monoclonales que reconocen al menos un epitopo de dicho peptido, asi como aplicaciones de este para la sintesis de anticuerpos neutralizantes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19900927 |
|
FG3A | Patent granted, date of granting |
Effective date: 19961127 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20000531 |